Related Experiment Video
Updated: Jul 8, 2026
08:51
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
Nanoparticles as nonviral gene delivery vectors
Andrea Ragusa1, Isabel García, Soledad Penadés
1Laboratory of Glyconanotechnology, IIQ-CSIC, Americo Vespucio 49, 41092 Seville, Spain. andrea.ragusa@unile.it
IEEE Transactions on Nanobioscience
|January 26, 2008
Summary
Gene therapy uses vectors for treating diseases. Nonviral vectors are gaining attention for safer gene delivery compared to viral methods, overcoming safety concerns.
Area of Science:
- Biotechnology
- Molecular Biology
- Genetics
Background:
- Gene therapy offers potential treatments for genetic and acquired diseases.
- Viral vectors have historically dominated gene delivery but pose safety concerns.
- Nonviral vectors are emerging as a safer alternative in gene therapy.
Purpose of the Study:
- To review the biological aspects of gene delivery.
- To explore recent advancements in nonviral gene carriers.
- To highlight the achievements of nonviral gene delivery systems.
Main Methods:
- Literature review of gene therapy research.
- Analysis of biological processes in gene delivery.
- Examination of nonviral vector development and applications.
Main Results:
- Nonviral vectors are increasingly studied for gene therapy applications.
- Significant progress has been made in developing effective nonviral gene carriers.
- Nonviral vectors show promise in overcoming the safety limitations of viral vectors.
Conclusions:
- Nonviral gene carriers represent a promising area of development in gene therapy.
- Further research into nonviral vectors can enhance the safety and efficacy of gene treatments.
- The field is moving towards safer and more efficient gene delivery strategies.
